... the company CEO updated recently. Cinnergen and Cinnechol have their website and TV ads are shown regularly for both. The launch of NumaDerm is set for June.

Now, EFSF says it will monitor the the progress. Let's see if our CEO will update us or will we have to wait for Quarterly reports.

Pur Effect is not mentioned, this time. Another delay? It would be nice to know how the Immune Bars are doing. As for OraPhyte, we'll have to wait for DuPont and their test results at three Southern Universities.

Now around .20, still a good entry point, imo. Your DD, your money.

go